IRIS
BRUGNOLO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.489
Totale 9.489
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.489
Totale 9.489
Salva come PNG Salva come JPEG
Città #
Genova 6.358
Rapallo 1.189
Genoa 995
Vado Ligure 913
Bordighera 34
Totale 9.489
Salva come PNG Salva come JPEG
Nome #
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 175
An updated Italian normative dataset for the Stroop color word test (SCWT) 175
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 162
A normative study of the Italian printed word version of the free and cued selective reminding test 154
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 152
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 144
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 139
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 134
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 133
Cortical sources of awake scalp EEG in eating disorders 132
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 131
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 131
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 131
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 130
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 129
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. 128
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 128
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 127
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 127
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 126
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 126
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 123
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 123
The Von Restorff effect in ageing and Alzheimer's disease. 123
What predicts cognitive decline in de novo Parkinson's disease? 123
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 120
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 119
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 117
Parkinson’s Disease Sleep Scale 2: application in an Italian population 117
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 116
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 115
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 114
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 114
Early identification of MCI converting to AD: a FDG PET study 113
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 112
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 111
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 107
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 104
The value of SPECT in detecting Alzheimer-type neurodegeneration in mild cognitive impairment 100
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 99
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 98
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 96
Cognitive function in patients with carotid stenosis: preliminary data on the use of the WAIS-R. 95
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 94
MCI patients declining and not declining at mid-term follow-up: FDG PET findings. Annual Congress of the European Association of Nuclear Medicine 94
MMSE factorial analysis in Alzheimer’s disease. 94
Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. 94
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 93
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic disease Clin Exp Rheumatol 93
Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes 93
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 92
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 92
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 91
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 91
Dehydroepiandrosterone sulphate and its correlation with clinical and hormonal parameters in eating disorders. 90
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 90
Principal component analysis of FDG PET in amnestic MCI 89
SPECT-Memory correlation in very mild Alzheimer’s disease. Effect of correlation for the severity of global cognitive impairment. 89
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 87
Do we need a 99mTc-ECD template for SPM SPECT studies? 86
Metabolic Networks Involved in Cognitive Reserve in Prodromal Alzheimer's Disesase (pAD): A European Alzheimer's Disease Consortium (EADC) Project 85
The need of appropriate brain spect templates for spm comparisons 83
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 83
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 82
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 82
Cognitive correlates of nigrostriatal dysfunction in de novo Parkinson’s disease (PD) 78
Mapping memory impairment and conversion patterns in aMCI patients: a combined VBM and PET study 76
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 75
The visual search test: analysis of sensitivity of the global score and of the three items in mild Alzheimer’s disease 74
Cortical sources of awakening scalp EEG in eating disorders. 74
Consistency of neuropsychiatric syndromes across dementias: Results from the european alzheimer disease consortium. Part ii 73
Integrated neurophysiological approach to Parkinson’s disease: preliminary data. 72
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 72
Principal component analysis of FDG PET in amnestic MCI 72
Semantic memory impairment and geographic space recognition in Alzheimer’s disease 72
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 71
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 71
The organization of the neuropsychiatric "macro"- UVA at IRCCS AOU "San Martino-IST", Genova. 70
null 70
Funzioni attentive nell’anoressia nervosa: dati neurofisiologici preliminar 69
null 67
Is Euro a cognitive chellenge for the elderly? 65
Manuale del Caregiver – Per chi si prende cura della persona malata di Alzheimer 65
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 64
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 63
Evidence of posterior cortical dysfunction in de novo, drug-naïve Parkinson’s disease (PD) 59
The Stroop color and word test (SCWT): preliminary normal data in an Italian population 59
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 59
The 16 item-printed word version of the free and cued selective reminding test (FCSRT): normal values in an italian population 53
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 53
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 52
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 52
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 50
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 48
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 46
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 45
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 42
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 39
Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment 32
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 31
Totale 9.473
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.460
article - articoli 25.267
book - libri 0
conference - conferenze 5.719
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 474
Totale 62.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.388 0 0 0 0 0 0 330 143 213 393 227 82
2020/2021696 37 74 61 65 26 54 56 57 57 75 64 70
2021/20221.226 32 66 114 151 52 83 67 256 50 116 50 189
2022/20231.355 102 95 21 147 211 222 4 116 248 18 148 23
2023/2024785 44 104 10 91 68 139 52 42 40 22 53 120
2024/20251.016 82 164 52 160 277 280 1 0 0 0 0 0
Totale 9.627